Observational studyClinical and experimental nephrology2017

Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease.

Norihiko Morisawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.